Multiple Manufacturers

CEFTAZIDIME

Manufacturer:

Multiple Manufacturers

Ceftazidime HCPCS:

J0713

HCPCS Code Descriptor:

Injection, ceftazidime, per 500 mg

Category:

J Code

Ceftazidime NDCs:

00264-3145-11, 00264-3143-11, 24987-0434-00, 00409-5086-11, 24987-0435-00, 52565-0107-10, 25021-0129-99, 00409-5092-16, 44567-0237-06, 25021-0129-69, 25021-0127-20, 00409-5093-11, 52565-0106-10, 24987-0378-10, 44567-0235-25, 25021-0128-50, 00409-5082-16, 44567-0236-10, 00409-5084-11, 25021-0127-66, 52565-0105-10, 24987-0377-10, 25021-0128-67

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00264-3145-11, 00264-3143-11, 24987-0434-00, 24987-0435-00, 52565-0107-10, 25021-0129-69, 52565-0106-10, 24987-0378-10, 25021-0127-66, 52565-0105-10, 24987-0377-10, 25021-0128-67

About Ceftazidime:

CEFTAZIDIME is an Antibiotic drug manufactured by Sagent and administered via the Injection route of administration. The J Code: J0713 is aligned to the drug CEFTAZIDIME.

ACCESS PRICING AND MORE BY REGISTERING

J0713 Added Date:

January 1, 1996

J0713 Effective Date:

January 1, 1997

J0713 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ceftazidime billing and coding information.
Our team did not identify a source for Ceftazidime patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for CEFTAZIDIME
Our team has not yet identified a source of side effects information for CEFTAZIDIME. Please check back in a few weeks.